HER2/NEU POSITIVE
Clinical trials for HER2/NEU POSITIVE explained in plain language.
Never miss a new study
Get alerted when new HER2/NEU POSITIVE trials appear
Sign up with your email to follow new studies for HER2/NEU POSITIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope: Pre-Surgery combo shrinks breast tumors
Disease control OngoingThis study tested whether giving chemotherapy (paclitaxel and cyclophosphamide) with or without the targeted drug trastuzumab before surgery helps shrink breast cancer tumors in 92 women with early-stage or locally advanced breast cancer. The goal was to see if the treatment redu…
Matched conditions: HER2/NEU POSITIVE
Phase: PHASE2 • Sponsor: University of Nebraska • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
New drug Z-Endoxifen shows promise in early breast cancer trial
Disease control OngoingThis early-phase trial tested a drug called Z-endoxifen in 62 women with estrogen receptor-positive (ER+) breast cancer that had spread or come back. The main goal was to find the safest dose and understand side effects. Z-endoxifen works by blocking estrogen, which can fuel brea…
Matched conditions: HER2/NEU POSITIVE
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 13, 2026 16:04 UTC